{
    "organizations": [],
    "uuid": "282d5e0da40a0ded9c6abff18cb76d540e09a876",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shandong-xinhua-pharmaceutical-say/brief-shandong-xinhua-pharmaceutical-says-h-share-trading-to-continue-idUSFWN1PJ0V0",
    "ord_in_thread": 0,
    "title": "BRIEF-Shandong Xinhua Pharmaceutical Says H Share Trading To Continue",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 24 (Reuters) - Shandong Xinhua Pharmaceutical Co Ltd :\n* ‍APPLIED TO SHENZHEN STOCK EXCHANGE FOR SUSPENSION OF TRADING OF A SHARES ON SZSE WITH EFFECT FROM 25 JAN 2018​\n* TRADING OF H SHARES OF CO WILL NOT BE AFFECTED AND WILL CONTINUE\n* TO RESUME A SHARE TRADING AFTER REVIEWING & APPROVING PLAN TO ISSUE CONSIDERATION SHARES FOR POTENTIAL ACQUISITION​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-24T20:35:00.000+02:00",
    "crawled": "2018-01-25T12:55:14.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "shandong",
        "xinhua",
        "pharmaceutical",
        "co",
        "ltd",
        "shenzhen",
        "stock",
        "exchange",
        "suspension",
        "trading",
        "share",
        "szse",
        "effect",
        "jan",
        "trading",
        "h",
        "share",
        "co",
        "affected",
        "continue",
        "resume",
        "share",
        "trading",
        "reviewing",
        "approving",
        "plan",
        "issue",
        "consideration",
        "share",
        "potential",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}